Literature DB >> 15031200

Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

D Wong, I Campbell, C Groenwald, E Lancaster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031200      PMCID: PMC1772099     

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  J B Jonas; I Kreissig; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.

Authors:  Mark C Gillies; Judy M Simpson; Wei Luo; Philip Penfold; Alex B L Hunyor; William Chua; Paul Mitchell; Frank Billson
Journal:  Arch Ophthalmol       Date:  2003-05

3.  Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration.

Authors:  Jost B Jonas; Ingrid Kreissig; Robert Degenring
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-10       Impact factor: 3.117

4.  Diurnal intraocular pressure variation in low-tension glaucoma.

Authors:  C De Vivero; C O'Brien; L Lanigan; R Hitchings
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

5.  Diurnal intraocular pressure. Correlation to automated perimetry.

Authors:  J Smith
Journal:  Ophthalmology       Date:  1985-07       Impact factor: 12.079

6.  The diurnal variation of intraocular pressure in non-glaucomatous subjects: relevance in a clinical context.

Authors:  J S Pointer
Journal:  Ophthalmic Physiol Opt       Date:  1997-11       Impact factor: 3.117

7.  Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study Group.

Authors:  D W Blackhurst; M G Maguire
Journal:  Retina       Date:  1989       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.